Caplin Point's board met and approved the consolidated financial results for the quarter ending June 30, 2025. Total Revenue rose 11.7% year-over-year to ₹533.4 Cr, with Net Profit increasing 20.7% to ₹150.8 Cr. Basic EPS reached ₹20.10. The board also proposed a final dividend of ₹3 per equity share for FY25, bringing the total dividend for the year to ₹6 per share (including interim). Strategic acquisitions include Neo Ethicals Chile SpA and Triwin Pharma S.A DE C.V (Mexico). Free cash reserves stand strong at ₹1,237 Cr.